The promise for T-cell therapies has jumped from their success in refractory blood cancers to approaching solid tumors, autoimmune conditions, and anti-scarring, along with many new ways to engineer the cells https://
erictopol.substack.com/p/engineering-
t-cells
…

→ View original post on X — @erictopol,